Day One Biopharmaceuticals, Inc. — All Filings
457 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
144
3
4
4/A
424B4
424B5
5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
EFFECT
PRE 14A
S-1
S-1/A
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC 14D9
SC TO-C
SC TO-T
SC TO-T/A
SC14D9C
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0000102909-26-001086 | Mar 26, 2026 | — |
| SC TO-T/A | SC TO-T/A | 0001193125-26-126206 | Mar 26, 2026 | — |
| SC 14D9 | SC 14D9 | 0001193125-26-125045 | Mar 26, 2026 | — |
| SC TO-T | SC TO-T | 0001193125-26-124957 | Mar 26, 2026 | — |
| SC TO-C | SC TO-C | 0001193125-26-119687 | Mar 23, 2026 | — |
| SCHEDULE 13G | — | 0001076809-26-000031 | Mar 19, 2026 | — |
| 8-K/A | 8-K/A | 0001193125-26-098851 | Mar 9, 2026 | Jan 6, 2026 |
| SC TO-C | SC TO-C | 0001193125-26-097262 | Mar 9, 2026 | — |
| SC TO-C | SC TO-C | 0001193125-26-095178 | Mar 6, 2026 | — |
| SC14D9C | SC14D9C | 0001193125-26-095176 | Mar 6, 2026 | — |
| 8-K | 8-K | 0001193125-26-095174 | Mar 6, 2026 | — |
| 8-K | 8-K | 0001193125-26-084267 | Mar 2, 2026 | — |
| 10-K | 10-K | 0001193125-26-066956 | Feb 24, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001193125-26-066926 | Feb 24, 2026 | — |
| 4 | — | 0001855298-26-000004 | Feb 18, 2026 | Feb 15, 2026 |
| 4 | — | 0001744507-26-000004 | Feb 18, 2026 | Feb 15, 2026 |
| 4 | — | 0001655962-26-000004 | Feb 18, 2026 | Feb 15, 2026 |
| 4 | — | 0001863107-26-000004 | Feb 18, 2026 | Feb 15, 2026 |
| 4 | — | 0001734755-26-000004 | Feb 18, 2026 | Feb 15, 2026 |
| 144 | — | 0001950047-26-001417 | Feb 17, 2026 | — |
| 144 | — | 0001950047-26-001416 | Feb 17, 2026 | — |
| 144 | — | 0001950047-26-001414 | Feb 17, 2026 | — |
| 144 | — | 0001950047-26-001412 | Feb 17, 2026 | — |
| SCHEDULE 13G | — | 0000902664-26-001078 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0000315066-26-000409 | Feb 5, 2026 | — |
| 4 | — | 0001655962-26-000002 | Jan 30, 2026 | — |
| 4 | — | 0001734755-26-000002 | Jan 30, 2026 | — |
| 4 | — | 0001863107-26-000002 | Jan 30, 2026 | — |
| 4 | — | 0001855298-26-000002 | Jan 30, 2026 | — |
| 4 | — | 0001744507-26-000002 | Jan 30, 2026 | — |
| 8-K | 8-K | 0001193125-26-009834 | Jan 12, 2026 | Jan 11, 2026 |
| 8-K | FORM 8-K | 0001104659-26-001127 | Jan 6, 2026 | — |
| SC TO-T/A | SC TO-T/A | 0001104659-26-001116 | Jan 6, 2026 | — |
| SC TO-T/A | SC TO-T/A | 0001104659-25-124535 | Dec 29, 2025 | — |
| SC TO-T | SC TO-T | 0001104659-25-118858 | Dec 5, 2025 | — |
| SC TO-C | SC TO-C | 0001104659-25-118456 | Dec 4, 2025 | — |
| 4 | — | 0001863107-25-000007 | Nov 26, 2025 | Nov 25, 2025 |
| 8-K | 8-K | 0001193125-25-292096 | Nov 24, 2025 | — |
| 4 | — | 0001744507-25-000006 | Nov 18, 2025 | Nov 15, 2025 |
| 4 | — | 0001655962-25-000006 | Nov 18, 2025 | Nov 15, 2025 |
| 4 | — | 0001855298-25-000007 | Nov 18, 2025 | Nov 15, 2025 |
| 4 | — | 0001863107-25-000005 | Nov 18, 2025 | Nov 15, 2025 |
| 144 | — | 0001950047-25-008933 | Nov 17, 2025 | — |
| 144 | — | 0001950047-25-008931 | Nov 17, 2025 | — |
| 144 | — | 0001950047-25-008930 | Nov 17, 2025 | — |
| 144 | — | 0001950047-25-008926 | Nov 17, 2025 | — |
| SC TO-C | SC TO-C | 0001104659-25-112478 | Nov 14, 2025 | — |
| SC TO-C | SC TO-C | 0001104659-25-110833 | Nov 13, 2025 | — |
| SC TO-C | SC TO-C | 0001104659-25-110815 | Nov 13, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-110812 | Nov 13, 2025 | Nov 12, 2025 |